FDA Seeks Fines From Advanced Bionics And Execs For Not Filing Supplement

FDA is pursuing Advanced Bionics and its two co-CEOs for $1.1 million each in fines, alleging that the company did not file a PMA supplement for adding a vendor for a component of its cochlear implant

More from Archive

More from Medtech Insight